RTW levels up by adding Maraganore, promoting company creator Fong
In latest ‘retirement’ post, John Maraganore joins the team of an early Alnylam investor to help guide the firm’s next-gen portfolio companies
With the addition of John Maraganore as executive partner and the promotion of Peter Fong to partner and head of company creation, RTW aims to bolster its broad pipeline of newly minted to publicly traded biotechs with the guidance of the former Alnylam CEO and his new colleague, who brings his gRED and Flagship experience to lead the New York City firm’s newest companies.
RTW hired Fong in 2019 to head the firm’s company creation initiatives. He is now CEO of Yarrow Biotechnology Inc., a New York City start-up still in stealth mode that is developing antisense oligonucleotide (ASO) therapies for severe, genetically defined CNS diseases. His responsibilities have grown to include oversight of business development and corporate finance at the firm, which also invests in venture and crossover financings, public equity, and royalty and structured finance. ...